Pre-clinical and translational investigation
Strengthen efficacy and safety evidence using relevant preclinical models and translational data.
Offer overview
What this offer helps you achieve
Strengthen efficacy and safety evidence using relevant preclinical models and translational data.
Scientific and technical scope
CALYM brings together experts, tools, models and collection to address challenges in Lymphoid malignancies research (lymphomas, multiple myeloma, CLL), in terms of: Development of new in vitro and in vivo models Functional immunology Study of the tumor microenvironment Study of the molecular heterogeneity Identification of blood and tissue biomarkers
Capabilities mobilised
Therapeutic areasTherapeutic target discoveryValidation using preclinical modelsBiomarkers
Application fields
Oncology
Discuss this offer
Could this capability strengthen your R&D programme?
Present your scientific, technical or clinical need and identify the most relevant route to collaboration.
Continue exploring
Related expertise for your programme
Offers selected through shared capabilities, application fields or institute expertise.
